Consolidation therapy with autologous blood stem cell transplantation in a patient with primary plasma cell leukaemia

Clinical and Laboratory Haematology

Volumn 25, Issue 1, 2003, Pages 55-58

  Mak, Yiu Kwong ^a   Chan, C H ^a   Chen, Y T ^a   Lau, S M ^a   So, C C ^a   Wong, K F ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Autologous stem cell transplantation; Molecular remission; Plasma cell leukaemia

Indexed keywords

ALKYLATING AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; PREDNISONE; RECOMBINANT ALPHA INTERFERON; VINCRISTINE;

ADULT; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CASE REPORT; CLINICAL PROTOCOL; DRUG MEGADOSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN TISSUE; MAINTENANCE THERAPY; MALE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PERIPHERAL BLOOD STEM CELL; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; INTERFERON-ALPHA; LEUKEMIA, PLASMACYTIC; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REMISSION INDUCTION; TRANSPLANTATION, AUTOLOGOUS;

EID: 0037330512     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.2003.00485.x     Document Type: Article

References (12)

1. Cai Z.J. (1990) Primary plasma cell leukaemia - a comprehensive analysis of 44 cases. Zhonghua Zhong Liu Za Zhi 12, 314-317.
2. Costello R., Sainty D., Bouabdallah R., Fermand J.P., Delmer A., Divine M., Marolleau J.P., Gastaut J.A., Olive D., Rousselot P. & Chaibi P. (2001) Primary plasma cell leukaemia: a report of 18 cases. Leukaemia Research 25, 103-107.
3. Dimopoulos M.A., Palumbo A., Delasalle K.B. & Alexanian R. (1994) Primary plasma cell leukaemia. British Journal of Haematology 88, 754-759.
4. Diss T.C., Peng H., Wotherspoon A.C., Isaacson P.G. & Pan L. (1993) Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. Journal of Clinical Pathology 169, 291-295.
5. Grogan T.M., Muller-Hermelink H.K., Van Camp B., Harris N.L. & Kyle R.A. (2001) World Health Organization Classification Tumours of Haematopoietic and Lymphoid Tissues. IARC Press Lyon, France. 142-156.
6. Hovenga S., Wolf de J.Th.M., Klip H. & Vellenga E. (1997) Consolidation therapy with autologous stem cell transplantation in plasma cell leukaemia after VAD. high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literature. Bone Marrow Transplantation 20, 901-904.
7. McElwain T.J. & Powles R.L. (1983) High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet 2, 822-824.
8. Montecucco C., Riccardi A., Merlini G. & Ascari E. (1986) Complete remission in plasma cell leukaemia. British Journal of Haematology 62, 525-527.
9. Noel P. & Kyle R.A. (1987) Plasma cell leukaemia: an evaluation of response to therapy. American Journal of Medicine 3, 1062-1068.
10. Sica S., Chiusolo P., Salutari P., Piccirillo N., Laurenti L., Ortu La Barbera E., Serra F.G. & Leone G. (1998) Long lasting complete remission in plasma cell leukaemia after aggressive chemotherapy and CD34-selected autologous peripheral blood progenitor cell transplant: molecular follow-up of minimal residual disease. Bone Marrow Transplantation 22, 823-825.
11. Yamada M., Hudson S., Tournay O., Bittenberder S., Shane S.S., Lange B., Tsujimoto Y., Caton A.J. & Rovera G. (1989) Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complimentarity-determining region (CDR-III)-specific probes. Proceedings of the National Academy of Sciences of the United States of America 86, 5123-5127.
12. Yeh K.H., Lin M.T., Tang J.L., Yang C.H., Tsay W. & Chen Y.C. (1995) Long-term disease-free survival after autologous bone marrow transplantation in a primary plasma cell leukaemia: detection of minimal residual disease in the transplant marrow by third-complementarity-determining region-specific probes. British Journal of Haematology 89, 914-916.